UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis

Journal of musculoskeletal & neuronal interactions, 2008-04, Vol.8 (2), p.94-104

2008

Link zum Volltext

Verfügbarkeit prüfen

Agonist-Specific Regulation of Parathyroid Hormone (PTH) Receptor Type 2 Activity: Structural and Functional Analysis of PTH- and Tuberoinfundibular Peptide (TIP) 39-Stimulated Desensitization and Internalization

Molecular endocrinology (Baltimore, Md.), 2004-06, Vol.18 (6), p.1486-1498

2004

Link zum Volltext

Verfügbarkeit prüfen

Are osteoclasts necessary for PTH bone forming actions? Evidence in ovariectomized huRANKL knock-in mice treated with denosumab or alendronate

Bone (New York, N.Y.), 2009-06, Vol.44, p.S226-S226

2009

Link zum Volltext

Verfügbarkeit prüfen

Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone?

The Journal of biological chemistry, 2010-09, Vol.285 (36), p.28164-28173

2010

Link zum Volltext

Verfügbarkeit prüfen

Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL

The Journal of biological chemistry, 2010-09, Vol.285 (36), p.28164-28173

2010

Link zum Volltext

Verfügbarkeit prüfen

Arrestin-regulated genes in osteoblasts exposed to intermittent or continuous PTH

Bone (New York, N.Y.), 2006-03, Vol.38 (3), p.8-8

2006

Link zum Volltext

Verfügbarkeit prüfen

β‐Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice

Journal of bone and mineral research, 2009-05, Vol.24 (5), p.775-784

2009

Link zum Volltext

Verfügbarkeit prüfen

β‐Arrestin2 Regulates the Differential Response of Cortical and Trabecular Bone to Intermittent PTH in Female Mice

Journal of bone and mineral research, 2005-04, Vol.20 (4), p.635-643

2005

Link zum Volltext

Verfügbarkeit prüfen

Biochemical Markers of Bone Fragility in Patients With Diabetes

The journal of clinical endocrinology and metabolism, 2023-05, Vol.108 (10), p.e923-e936

2023

Link zum Volltext

Verfügbarkeit prüfen

Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS

The journal of clinical endocrinology and metabolism, 2023-05

2023

Link zum Volltext

Verfügbarkeit prüfen

Bone fragility in patients affected by congenital diseases non skeletal in origin

Orphanet journal of rare diseases, 2021-01, Vol.16 (1), p.11-11, Article 11

2021

Link zum Volltext

Verfügbarkeit prüfen

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors

Annals of oncology, 2019-06, Vol.30 (6), p.908-920

2019

Link zum Volltext

Verfügbarkeit prüfen

Bone management in hematologic stem cell transplant recipients

Osteoporosis international, 2018-12, Vol.29 (12), p.2597-2610

2018

Link zum Volltext

Verfügbarkeit prüfen

Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2

Endocrinology (Philadelphia), 2005-04, Vol.146 (4), p.1854-1862

2005

Link zum Volltext

Verfügbarkeit prüfen

Bone Response to Intermittent Parathyroid Hormone Is Altered in Mice Null for β-Arrestin2

Endocrinology (Philadelphia), 2005-04, Vol.146 (4), p.1854-1862

2005

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated bone disease

Osteoporosis international, 2013-12, Vol.24 (12), p.2929-2953

2013

Link zum Volltext

Verfügbarkeit prüfen

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

Osteoporosis international, 2013-08, Vol.24 (8), p.2135-2152

2013

Link zum Volltext

Verfügbarkeit prüfen

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

Journal of clinical densitometry, 2017, Vol.20 (1), p.8-24

2017

Link zum Volltext

Verfügbarkeit prüfen

Characterizaton of Short Isoforms of the Leptin Receptor in Rat Cerebral Microvessels and of Brain Uptake of Leptin in Mouse Models of Obesity

Endocrinology (Philadelphia), 2002-03, Vol.143 (3), p.775-783

2002

Link zum Volltext

Verfügbarkeit prüfen

Chronic Administration of Leptin into the Lateral Ventricle Induces Sexual Maturation in Severely Food-restricted Female Rats

Journal of neuroendocrinology, 1998-08, Vol.10 (8), p.627-633

1998

Link zum Volltext

Verfügbarkeit prüfen

Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats

Endocrinology (Philadelphia), 1996-01, Vol.137 (1), p.3-12

1996

Link zum Volltext

Verfügbarkeit prüfen

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism

Molecular and cellular endocrinology, 2001-12, Vol.185 (1), p.195-204

2001

Link zum Volltext

Verfügbarkeit prüfen

Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat

Neuroendocrinology, 1995-03, Vol.61 (3), p.293

1995

Link zum Volltext

Verfügbarkeit prüfen

Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys : Potential signals for the initiation of puberty. Editorial

The journal of clinical endocrinology and metabolism, 2000, Vol.85 (2), p.804-814

2000

Link zum Volltext

Verfügbarkeit prüfen

Combined treatment with a β-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice

Bone (New York, N.Y.), 2006-08, Vol.39 (2), p.260-267

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(93)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(56)
Endocrinology & Metabolism
(40)
Animals
(35)
Humans
(30)
Orthopedics
(24)
Endocrinology
(23)
Male
(23)
Female
(22)
Mice
(22)
Biological And Medical Sciences
(18)
Medicine
(18)
Osteoporosis
(17)
Rats
(16)
Medicine & Public Health
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)
Rheumatology
(14)
Endocrinology, Diabetes And Metabolism
(13)
Rats, Sprague-Dawley
(12)
Bone And Bones - Drug Effects
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis

Agonist-Specific Regulation of Parathyroid Hormone (PTH) Receptor Type 2 Activity: Structural and Functional Analysis of PTH- and Tuberoinfundibular Peptide (TIP) 39-Stimulated Desensitization and Internalization

Are osteoclasts necessary for PTH bone forming actions? Evidence in ovariectomized huRANKL knock-in mice treated with denosumab or alendronate

Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone?

Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL

Arrestin-regulated genes in osteoblasts exposed to intermittent or continuous PTH

β‐Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice

β‐Arrestin2 Regulates the Differential Response of Cortical and Trabecular Bone to Intermittent PTH in Female Mice

Biochemical Markers of Bone Fragility in Patients With Diabetes

Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS

Bone fragility in patients affected by congenital diseases non skeletal in origin

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors

Bone management in hematologic stem cell transplant recipients

Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2

Bone Response to Intermittent Parathyroid Hormone Is Altered in Mice Null for β-Arrestin2

Cancer-associated bone disease

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

Characterizaton of Short Isoforms of the Leptin Receptor in Rat Cerebral Microvessels and of Brain Uptake of Leptin in Mouse Models of Obesity

Chronic Administration of Leptin into the Lateral Ventricle Induces Sexual Maturation in Severely Food-restricted Female Rats

Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism

Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat

Circulating concentrations of nocturnal leptin, growth hormone, and insulin-like growth factor-I increase before the onset of puberty in agonadal male monkeys : Potential signals for the initiation of puberty. Editorial

Combined treatment with a β-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice

Suchergebnisse filtern